Ann: Quarterly Cashflow Report, page-8

I strongly suggest not to be the first out of block and denegrate management

The quarterly is excellent

Why don't you guys/girls read it properly......before putting out derogatory remarks

As far as FDA NDA saga is going.......that's the way the cookie crumbles....The company is going down a dual path for approval......update!!! was given today

Of course...what went wrong ....still needs to be answered.....and it will be at AGM.....with the number one question on shareholders minds


Meanwhile life goes on

2 new patents filed

Completion of dose escalation with data to be made public and DEP Cabazitaxel going into phase 2

Azd0046 beginning clinical trial

2 new anticancer drugs in preclinical